374 related articles for article (PubMed ID: 19432109)
1. [Drug selection guide for osteoporosis determined by the clinical staging, pathophysiology and age].
Tanaka I; Oshima H
Nihon Rinsho; 2009 May; 67(5):915-20. PubMed ID: 19432109
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].
Azuma K
Clin Calcium; 2009 Sep; 19(9):1345-52. PubMed ID: 19721208
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of osteoporosis in octogenarians].
Pepersack T
Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982
[TBL] [Abstract][Full Text] [Related]
4. [Osteoporosis treatment].
Uebelhart B; Rizzoli R
Rev Med Suisse; 2006 Jan; 2(47):47-51. PubMed ID: 16465945
[TBL] [Abstract][Full Text] [Related]
5. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
6. [Bone quality].
Ito M
Nihon Rinsho; 2009 May; 67(5):921-5. PubMed ID: 19432110
[TBL] [Abstract][Full Text] [Related]
7. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
8. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
Muscoso E; Puglisi N; Mamazza C; Lo Giudice F; Testai M; Abbate S; Santangelo A; Panebianco P; Maugeri D
Eur Rev Med Pharmacol Sci; 2004; 8(2):97-102. PubMed ID: 15267123
[TBL] [Abstract][Full Text] [Related]
9. [Pharmaceutical treatment for patients with hip fracture].
Hagino H
Clin Calcium; 2010 Sep; 20(9):1394-400. PubMed ID: 20808048
[TBL] [Abstract][Full Text] [Related]
10. A rational approach to evidence gaps in the management of osteoporosis.
Rosen CJ; Brown SA
Am J Med; 2005 Nov; 118(11):1183-9. PubMed ID: 16271898
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture.
Bouvet A; Sabatier B; Savoldelli V; Caruba T; Pouchot J
J Clin Rheumatol; 2014 Sep; 20(6):347-8. PubMed ID: 25160027
[No Abstract] [Full Text] [Related]
12. Postmenopausal osteoporosis: fracture risk and prevention.
Kaunitz AM; McClung MR; Feldman RG; Wysocki S
J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
[TBL] [Abstract][Full Text] [Related]
13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonate or Raloxifene?: which drug we can choose for osteoporotic patients?].
Miki T; Saito S
Clin Calcium; 2006 Jan; 16(1):167-74. PubMed ID: 16397368
[TBL] [Abstract][Full Text] [Related]
15. [Combination therapy for osteoporosis].
Kishimoto H
Nihon Rinsho; 2009 May; 67(5):975-9. PubMed ID: 19432119
[TBL] [Abstract][Full Text] [Related]
16. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
[TBL] [Abstract][Full Text] [Related]
17. [Progress in the treatment of osteoporosis].
Sugimoto T
Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
Nishida A; Ito M
Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
[TBL] [Abstract][Full Text] [Related]
19. Treatment of osteoporosis: all the questions we still cannot answer.
Laroche M
Am J Med; 2008 Sep; 121(9):744-7. PubMed ID: 18724959
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of osteoporosis.
Lash RW; Nicholson JM; Velez L; Van Harrison R; McCort J
Prim Care; 2009 Mar; 36(1):181-98, x. PubMed ID: 19231609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
